ZBH Zimmer Biomet Holdings Inc
Price (delayed)
$107.57
Market cap
$21.41B
P/E Ratio
24.17
Dividend/share
$0.96
EPS
$4.45
Enterprise value
$27.09B
Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of
Highlights
ZBH's P/E is 72% lower than its 5-year quarterly average of 86.2
ZBH's quick ratio is up by 44% QoQ and by 26% YoY
The debt has increased by 8% year-on-year but it has declined by 3.8% since the previous quarter
The net income has declined by 17% since the previous quarter and by 12% year-on-year
The EPS has contracted by 16% from the previous quarter and by 9% YoY
Key stats
What are the main financial stats of ZBH
Market
Valuations
Earnings
Shares outstanding
199.06M
Market cap
$21.41B
Enterprise value
$27.09B
Price to earnings (P/E)
24.17
Price to book (P/B)
1.72
Price to sales (P/S)
2.85
EV/EBIT
21.62
EV/EBITDA
12.04
EV/Sales
3.53
Revenue
$7.68B
Gross profit
$5.49B
Operating income
$1.29B
Net income
$903.8M
EBIT
$1.25B
EBITDA
$2.25B
Free cash flow
-$444.1M
Per share
Balance sheet
Liquidity
EPS
$4.45
EPS diluted
$4.43
Free cash flow per share
-$2.19
Book value per share
$62.63
Revenue per share
$37.81
TBVPS
$38.48
Total assets
$21.37B
Total liabilities
$8.89B
Debt
$6.2B
Equity
$12.47B
Working capital
$2.22B
Debt to equity
0.5
Current ratio
1.91
Quick ratio
0.82
Net debt/EBITDA
2.52
Margins
Efficiency
Dividend
EBITDA margin
29.3%
Gross margin
71.5%
Net margin
11.8%
Operating margin
16.7%
Return on assets
4.2%
Return on equity
7.2%
Return on invested capital
12%
Return on capital employed
6.6%
Return on sales
16.3%
Dividend yield
0.89%
DPS
$0.96
Payout ratio
21.6%
ZBH stock price
How has the Zimmer Biomet Holdings stock price performed over time
Intraday
3.4%
1 week
2.14%
1 month
7.67%
1 year
-15.02%
YTD
1.84%
QTD
1.84%
Financial performance
How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.68B
Gross profit
$5.49B
Operating income
$1.29B
Net income
$903.8M
Gross margin
71.5%
Net margin
11.8%
The net margin has declined by 17% since the previous quarter and by 14% year-on-year
The net income has declined by 17% since the previous quarter and by 12% year-on-year
The revenue has grown by 3.8% YoY
Zimmer Biomet Holdings's operating margin has decreased by 3.5% YoY
Growth
What is Zimmer Biomet Holdings's growth rate over time
Valuation
What is Zimmer Biomet Holdings stock price valuation
P/E
24.17
P/B
1.72
P/S
2.85
EV/EBIT
21.62
EV/EBITDA
12.04
EV/Sales
3.53
ZBH's P/E is 72% lower than its 5-year quarterly average of 86.2
The EPS has contracted by 16% from the previous quarter and by 9% YoY
The stock's P/B is 18% below its 5-year quarterly average of 2.1 and 4.4% below its last 4 quarters average of 1.8
ZBH's price to sales (P/S) is 25% lower than its 5-year quarterly average of 3.8 and 8% lower than its last 4 quarters average of 3.1
The revenue has grown by 3.8% YoY
Efficiency
How efficient is Zimmer Biomet Holdings business performance
The ROA has contracted by 16% from the previous quarter and by 13% YoY
Zimmer Biomet Holdings's return on equity has decreased by 16% QoQ and by 13% YoY
The ROS has contracted by 4.7% YoY
Dividends
What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.89%
Payout ratio
21.6%
Recent dividends
Special dividends are included in TTM DPS and yield
Financial health
How did Zimmer Biomet Holdings financials performed over time
The total assets is 140% higher than the total liabilities
ZBH's quick ratio is up by 44% QoQ and by 26% YoY
The current ratio has grown by 40% from the previous quarter and by 19% YoY
The debt is 50% smaller than the equity
The debt to equity has grown by 9% year-on-year but it has declined by 3.8% since the previous quarter
The debt has increased by 8% year-on-year but it has declined by 3.8% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.